Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 53, Issue 1, 2012, Pages 169-172

  Herold, Tobias ^a   Seiler, Till ^a   Egensperger, Rupert ^b   Trumm, Christoph ^a   Bergmann, Manuela ^a   Franke, Daniel ^a   Mumm, Friederike F H ^a   Schinwald, Nicole ^a   Buske, Christian ^c   Dreyling, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Center for Neuropathology and Prion Research   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CIDOFOVIR; CYCLOPHOSPHAMIDE; FLECAINIDE; FLUDARABINE; IMMUNOGLOBULIN; RITUXIMAB;

AGED; BRAIN BIOPSY; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL EXAMINATION; DRUG TREATMENT FAILURE; EMERGENCY CARE; HEART ARRHYTHMIA; HEMIANOPIA; HUMAN; HUMAN TISSUE; LETTER; LUMBAR PUNCTURE; MALE; MEDICAL HISTORY; MULTIPLE CYCLE TREATMENT; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; HEMIANOPSIA; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; VIDARABINE;

EID: 84855438011     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.608446     Document Type: Letter

References (15)

1. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009;113:4834-4840.
2. E gli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009;199:837-846.
3. H allek M, Fischer K, Fingerle-Rowson G, et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet 2010;376:1164-1174.
4. Ysebaert L, Gross E, Kuhlein E, et al. Immune recovery after fludarabine-cyclophosphamide-rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy. Leukemia 2010;24:1310-1316.
5. D ' S ouza A, Wilson J, Mukherjee S, et al. Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: a report of three cases and review of the literature. Clin Lymphoma Myeloma Leuk 2010;10:E1-E9.
6. Kiewe P, Seyfert S, Korper S, et al. Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy. Leuk Lymphoma 2003;44:1815-1818. (Pubitemid 37221060)
7. Foon KA, Boyiadzis M, Land SR, et al. Chemoimmunotherapy with low-dose fludarabine and cyclophosphamide and high dose rituximab in previously untreated patients with chronic lymphocytic leukemia. J Clin Oncol 2009;27:498-503.
8. B ollag B, Prins C, Snyder EL, et al. Purified JC virus T and T ' proteins diff erentially interact with the retinoblastoma family of tumor suppressor proteins. Virology 2000;274:165-178. (Pubitemid 30650691)
9. H amblin AD, Hamblin TJ. The immunodeficiency of chronic lymphocytic leukaemia. Br Med Bull 2008;87:49-62.
10. S crivener S, Goddard RV, Kaminski ER, et al. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia. Leuk Lymphoma 2003;44:383-389. (Pubitemid 36118829)
11. C id J, Revilla M, Cervera A, et al. Progressive multifocal leukoencephalopathy following oral fludarabine treatment of chronic lymphocytic leukemia. Ann Hematol 2000;79:392-395. (Pubitemid 30459665)
12. L anger-Gould A, Atlas SW, Green AJ, et al. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005;353:375-381. (Pubitemid 41132342)
13. W eide R, Mergenthaler U, Friesenhahn V, et al. Bendamustine/ mitoxantrone/rituximab: a short remission induction chemoim munotherapy for elderly patients with relapsed or refractory chronic lymphocytic leukemia. Leuk Lymphoma 2009;50:1468-1474.
14. C heson BD, Wendtner CM, Pieper A, et al. Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panel. Clin Lymphoma Myeloma Leuk 2010;10:21-27.
15. Eichhorst BF, Busch R, Stilgenbauer S, et al. First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia. Blood 2009;114:3382-3391.